Internal Medicine, Hematology & Oncology · Corpus Christi, TX
NPI
1164529806
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
1625 Rodd Field Rd Ste 100
Corpus Christi, TX, 78412
Phone (361) 887-0067
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.5M
224,936 services
Medicare patients, 2024
375
Average age 75
Drug cost, 2024
$7.1M
3,019 prescriptions
Company payments, 2025
$4,190
From 35 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ajay Sehgal was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 15,500 times for 14 patients. In total Ajay Sehgal billed 224,936 services in 108 codes, and Medicare paid $3.5M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-10-21.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 15,500 | 14 | $0.28 | $4,342 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 8,609 | 64 | $0.08 | $650 |
| J0897 Injection, denosumab, 1 mg | Office | 7,440 | 22 | $20.39 | $152K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 6,432 | 48 | $0.09 | $577 |
| 96367 Intravenous Infusion, Hydration | Office | 1,382 | 80 | $20.80 | $29K |
| 96413 Chemotherapy Administration | Office | 592 | 66 | $92.25 | $55K |
| Q5111 Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg | Office | 456 | 12 | $96.46 | $44K |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 419 | 58 | $0.64 | $268 |
| 99214 Office E&M - Established | Office | 400 | 225 | $89.05 | $36K |
| 96372 Injection Administration | Office | 336 | 59 | $10.22 | $3,434 |
| 96415 Chemotherapy Administration | Office | 190 | 28 | $20.29 | $3,856 |
| J9045 Injection, carboplatin, 50 mg | Office | 182 | 12 | $2.84 | $517 |
| 96417 Chemotherapy Administration | Office | 174 | 38 | $45.96 | $7,997 |
| 96409 Chemotherapy Administration | Office | 168 | 12 | $72.91 | $12K |
| J3490 Unclassified drugs | Office | 151 | 24 | $0.30 | $45.01 |
By year: 2022 $4.0M for 250,301 services; 2023 $4.9M for 293,781 services; 2024 $3.5M for 224,936 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ajay Sehgal prescribed most often to Medicare patients was Anastrozole, with 444 prescriptions and refills. In total Ajay Sehgal wrote 3,019 Medicare prescriptions that cost $7.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 444 | 1,177 | 140 | $5,701 |
| Tamoxifen Citrate Generic | 223 | 568 | 64 | $6,016 |
| Ondansetron Hcl Generic | 207 | 207 | 149 | $1,509 |
| Zarxio Filgrastim-Sndz | 169 | 169 | 35 | $124K |
| Valacyclovir Valacyclovir Hcl | 155 | 275 | 51 | $5,768 |
| Dexamethasone Generic | 106 | 156 | 66 | $1,655 |
| Hydroxyurea Generic | 92 | 228 | 28 | $2,352 |
| Prochlorperazine Maleate Generic | 92 | 92 | 59 | $1,546 |
| Gabapentin Generic | 77 | 91 | 24 | $1,170 |
| Cabometyx Cabozantinib S-Malate | 75 | 75 | 11 | $1.9M |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 72 | 72 | 60 | $959 |
| Procrit Epoetin Alfa | 67 | 67 | Under 11 | $75K |
| Letrozole Generic | 60 | 134 | 17 | $1,153 |
| Levothyroxine Sodium Generic | 56 | 96 | 14 | $328 |
| Meloxicam Generic | 55 | 55 | 23 | $83.25 |
Brand drugs: 758 claims; generic drugs: 2,261 claims; opioid claims: 42.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ajay Sehgal $4,190 ($4,190 in general payments such as food, travel and fees) from 35 companies. The largest payer was Novartis Pharmaceuticals Corporation with $1,206.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 23 | $1,206 |
| E.R. Squibb & Sons, L.L.C. BMY | 9 | $409 |
| Janssen Biotech, Inc. JNJ | 13 | $254 |
| AstraZeneca Pharmaceuticals LP AZN | 12 | $253 |
| Merck Sharp & Dohme LLC MRK | 10 | $248 |
| Astellas Pharma US Inc 4503.T | 8 | $146 |
| Celgene Corporation BMY | 8 | $144 |
| Pfizer Inc. PFE | 7 | $132 |
| Genmab U.S., Inc. GMAB | 1 | $124 |
| Abbvie Inc. ABBV | 5 | $91.85 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.